• Opposition to Key CRISPR Patent Rejected by JPO
    Michael Arciero

News & Views

Opposition to Key CRISPR Patent Rejected by JPO

Jun 01 2021

Opposition to a second Japanese patent, applied for in relation to the use of CRISPR methods in cellular studies, has been rejected by the Japanese Patent Office (JPO), reports ERS Genomics, the Dublin-based company providing access to this technology.

“The JPO actions reinforce the broad and fundamental nature of our CRISPR patent portfolio, both in Japan and worldwide.” Michael Arciero

Japanese patent (JP6692856), filed by CRISPR/Cas9 intellectual property co-owner Dr. Emannuelle Charpentier, together with The Regents of the University of California and University of Vienna (collectively known as CVC), covers compositions and methods for use in a variety of eukaryotic cells, in either dual-guide or single-guide format.

Patentability of inventions re-affirmed

During the JP6692856 proceedings, opponents’ contested novelty and inventive step. However, in its opposition decision to these arguments, the JPO upheld CVC’s application, further validating the fundamental value of these patents for use of the CRISPR/Cas9 technology. 

Third Patent also allowed

The JPO also granted patent JP2019-210828, covering compositions and uses of a chimeric version of the Cas9 protein in cellular and non-cellular settings, to the CVC Group.

Michael Arciero, Vice-President of Intellectual Property and Commercial Development, ERS Genomics, said:  “The JPO actions reinforce the broad and fundamental nature of our CRISPR patent portfolio, both in Japan and worldwide. This also validates the decision our licensees have made to work with ERS to enable their commercialisation efforts involving CRISPR/Cas9. We are expanding our efforts to make the technology broadly available, so it can be used by as many people as possible.”

Patents for this CRISPR technology have now been issued in over 80 countries worldwide.

Further information online


Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions

Events

ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia

Miconex

Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

EMC2024

Aug 25 2024 Copenhagen, Denmark

View all events